Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03456063
Title A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030)
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Hoffmann-La Roche
Indications

lung non-small cell carcinoma

Therapies

Carboplatin + Cisplatin + Nab-paclitaxel + Pemetrexed Disodium

Atezolizumab + Carboplatin + Cisplatin + Nab-paclitaxel + Pemetrexed Disodium

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | AUT

Additional content available in CKB BOOST